Anne Henriksen-Santerre
Jyllinge, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Performance of disc diffusion and four commercially available MIC tests to determine mecillinam susceptibility on carbapenemase-producing Enterobacterales.
Journal: Journal of clinical microbiology
Published: April 14, 2025
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infections: The Full Picture Combines Extensive Clinical Experience and Emerging Data.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 06, 2025
Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales.
Journal: Future microbiology
Published: February 26, 2025
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 04, 2025
In vivo efficacy of enmetazobactam combined with cefepime in a murine pneumonia model induced by OXA-48-producing Klebsiella pneumoniae.
Journal: Microbiology spectrum
Published: October 31, 2024
Safety and Tolerability of Pivmecillinam During More Than Four Decades of Clinical Experience: A Systematic Review.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 28, 2024
In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations.
Journal: Microbiology spectrum
Published: June 21, 2024
In vitro activity of cefepime-enmetazobactam on carbapenem-resistant Gram negatives.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: June 15, 2024
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations.
Journal: Microbiology spectrum
Published: March 14, 2024
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens.
Journal: Open forum infectious diseases
Published: February 28, 2024
Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis.
Journal: Microbiology spectrum
Published: November 15, 2023
Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic.
Journal: Open forum infectious diseases
Published: April 11, 2023
Last Updated: 09/26/2026